TrialJournal of clinical psychopharmacology

Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study.

Mona Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.